Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.410,00
0,11%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Olink Holding AB (OLK) Olink Holding AB (OLK) Notizie

OLK

Olink Holding AB (OLK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OLK
DataOraFonteTitoloSimboloCompagnia
06/06/202408:00GlobeNewswire Inc.Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute ConfidenceNASDAQ:OLKOlink Holding AB
30/05/202414:00GlobeNewswire Inc.Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before DiagnosisNASDAQ:OLKOlink Holding AB
13/05/202412:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OLKOlink Holding AB
13/05/202412:00GlobeNewswire Inc.Olink reports first quarter 2024 financial resultsNASDAQ:OLKOlink Holding AB
19/04/202422:05GlobeNewswire Inc.Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024NASDAQ:OLKOlink Holding AB
02/04/202414:00GlobeNewswire Inc.Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of DiseaseNASDAQ:OLKOlink Holding AB
25/03/202413:00GlobeNewswire Inc.Olink reports fourth quarter and full year 2023 financial resultsNASDAQ:OLKOlink Holding AB
25/03/202413:00GlobeNewswire Inc.Olink publishes 2023 annual reportNASDAQ:OLKOlink Holding AB
15/03/202413:00GlobeNewswire Inc.Notice to attend the Annual General Meeting of Olink Holding AB (publ)NASDAQ:OLKOlink Holding AB
08/03/202414:00GlobeNewswire Inc.Olink announces change of date for Annual General MeetingNASDAQ:OLKOlink Holding AB
01/03/202422:45Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:OLKOlink Holding AB
15/11/202313:00GlobeNewswire Inc.Olink reports third quarter 2023 financial resultsNASDAQ:OLKOlink Holding AB
06/11/202302:00GlobeNewswire Inc.Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomicsNASDAQ:OLKOlink Holding AB
31/10/202316:36Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:OLKOlink Holding AB
18/10/202300:40Business WireThermo Fisher Scientific prépare l'acquisition d'Olink, leader de la protéomique de nouvelle générationNASDAQ:OLKOlink Holding AB
18/10/202300:39Business WireThermo Fisher Scientific übernimmt Olink, ein führendes Unternehmen der Proteomik der nächsten GenerationNASDAQ:OLKOlink Holding AB
17/10/202323:28Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:OLKOlink Holding AB
17/10/202316:16Dow Jones NewsOlink Holding Shares Soar on Takeover by Thermo FisherNASDAQ:OLKOlink Holding AB
17/10/202315:01Dow Jones NewsThermo Fisher to Buy Olink in $3.1 Billion DealNASDAQ:OLKOlink Holding AB
17/10/202314:19Business WireThermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation ProteomicsNASDAQ:OLKOlink Holding AB
05/10/202322:25GlobeNewswire Inc.Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomicsNASDAQ:OLKOlink Holding AB
19/09/202309:00GlobeNewswire Inc.Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.NASDAQ:OLKOlink Holding AB
12/09/202317:00GlobeNewswire Inc.Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programsNASDAQ:OLKOlink Holding AB
29/08/202314:00GlobeNewswire Inc.Olink to participate in September investor eventsNASDAQ:OLKOlink Holding AB
18/08/202302:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLKOlink Holding AB
09/08/202313:00GlobeNewswire Inc.Olink reports second quarter 2023 financial resultsNASDAQ:OLKOlink Holding AB
08/08/202314:00GlobeNewswire Inc.Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platformNASDAQ:OLKOlink Holding AB
13/07/202314:00GlobeNewswire Inc.Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:OLKOlink Holding AB
12/07/202315:00GlobeNewswire Inc.Announcing Olink® Explore HT – A New Era in ProteomicsNASDAQ:OLKOlink Holding AB
28/06/202314:00GlobeNewswire Inc.Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studiesNASDAQ:OLKOlink Holding AB
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OLK

La tua Cronologia

BIT
UV4KR3
Unicredit Bank
USOTC
GISMF
Grupo Industrial Saltill... (GM)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network